Notes

1Guidance for Industry Process Validation: General Principles and Practices, FDA, Jan. 2011.


2Pluta, P.: FDA Life Cycle Approach to Process Validation—What, Why, and How. J. Validation Technology Spring, 51–61; 2011.



3Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice; FDA, Sep. 2004.


4Guide to the Inspections Validation of Cleaning Processes; FDA Jul. 1993.


5Title 21 Code of Federal Regulations Parts 210 and 211, 2015.


6Process Validation A Life Cycle Approach; Grace McNally; FDA May 2011 slide presentation on www.FDA.gov


7Ibid.


8Sending team—those responsible for the current operation and instrumental in training and transferring their knowledge to the receiving team.


9Guidance for Industry: CMC Postapproval Manufacturing Changes to be Documented in Annual Reports; FDA—Mar. 2014.


10Ostrove, S.: Qualification and Change Control. In: Validation of Pharmaceutical Processes, 3rd Ed; Editors: Agalloco, J., Carlton, F. New York: Informa Healthcare USA, Inc., 2008, pp. 129–145.


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 4, 2017 | Posted by in PHARMACY | Comments Off on Notes

Full access? Get Clinical Tree

Get Clinical Tree app for offline access